Cargando…

Optimal diagnosis and management of non-alcoholic fatty liver disease

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sciendo 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10321157/ https://www.ncbi.nlm.nih.gov/pubmed/37551399 http://dx.doi.org/10.2478/abm-2022-0001

Ejemplares similares

How to optimize the outcome of liver transplantation for non-alcoholic fatty liver disease
por: Song, Byeong Geun, et al.
Publicado: (2023)

Managing non‐alcoholic fatty liver disease in diabetes: Challenges and opportunities
por: Lee, Chi‐Ho, et al.
Publicado: (2016)

Multi-disciplinary clinic models for the management of non-alcoholic fatty liver disease
por: Zoncapè, Mirko, et al.
Publicado: (2022)

Non-invasive biomarkers of liver fibrosis in non-alcoholic fatty liver disease
por: Basheer, Maamon, et al.
Publicado: (2023)

Practice guidance documents for the diagnosis and management of non-alcoholic fatty liver disease—recent updates and open questions
por: Lauschke, Volker M.
Publicado: (2023)

The growing burden of non-alcoholic fatty liver disease on mortality
por: Cho, Ju-Yeon, et al.
Publicado: (2023)

Position statement on the diagnosis and management of non-alcoholic fatty liver disease
por: Alswat, Khalid A., et al.
Publicado: (2019)

Beyond Liver Disease: Non-Alcoholic Fatty Liver Disease and Advanced Liver Fibrosis in Kidney Disease
por: Han, Eugene
Publicado: (2022)

Non-invasive biomarkers for liver inflammation in non-alcoholic fatty liver disease: present and future
por: Chuah, Kee-Huat, et al.
Publicado: (2023)

Prevalence of frailty in patients with non-cirrhotic non-alcoholic fatty liver disease
por: O'Brien, Alastair
Publicado: (2022)

Comparing the Mortality Risk between Metabolic Dysfunction-Associated Fatty Liver Disease and Non-Alcoholic Fatty Liver Disease
por: Jung, Han Na, et al.
Publicado: (2023)

Current and emerging pharmacological therapy for non-alcoholic fatty liver disease
por: Eshraghian, Ahad
Publicado: (2017)

Nutritional Intake and the Risk for Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Schattenberg, Jörn M., et al.
Publicado: (2019)

An analysis of polygenic risk scores for non-alcoholic fatty liver disease
por: Jun, Dae Won
Publicado: (2021)

Non-invasive imaging biomarkers for liver steatosis in non-alcoholic fatty liver disease: present and future
por: Alnimer, Lynna, et al.
Publicado: (2023)

Should you advocate for hepatocellular carcinoma surveillance in patients with alcohol-related liver disease or non-alcoholic fatty liver disease?
por: Shim, Ju Hyun
Publicado: (2020)

Pediatric non-alcoholic fatty liver disease: current perspectives on diagnosis and management
por: Di Sessa, Anna, et al.
Publicado: (2019)

Non-alcoholic fatty liver disease: an update on diagnosis
por: DUMITRASCU, DAN L., et al.
Publicado: (2018)

From the liver to the heart: Cardiac dysfunction in obese children with non-alcoholic fatty liver disease
por: Di Sessa, Anna, et al.
Publicado: (2017)

The growing threat of non-alcoholic fatty liver disease-related hepatocellular carcinoma
por: Teng, Margaret L. P., et al.
Publicado: (2022)

Hepatocellular carcinoma surveillance in non-alcoholic fatty liver disease – who and how?
por: Teng, Margaret LP, et al.
Publicado: (2023)

An Overview of Dietary Interventions and Strategies to Optimize the Management of Non-Alcoholic Fatty Liver Disease
por: Perumpail, Brandon J., et al.
Publicado: (2017)

Editorial: International Consensus Recommendations to Replace the Terminology of Non-Alcoholic Fatty Liver Disease (NAFLD) with Metabolic-Associated Fatty Liver Disease (MAFLD)
por: Méndez-Sánchez, Nahum, et al.
Publicado: (2021)

What's in a disease like non‐alcoholic fatty liver disease—East versus West?
por: Dan, Yock Young
Publicado: (2022)

Hepatocellular Carcinoma and Non-Alcoholic Fatty Liver Disease: A Modern Context for an Ancient Disease
por: Gallo, Paolo, et al.
Publicado: (2023)

Targeting the ileal bile salt transporter in the treatment of non-alcoholic fatty liver disease
por: Jansen, Peter L. M.
Publicado: (2021)

Quantitative imaging tests for non-alcoholic fatty liver disease: which, when and why
por: Dennis, Andrea
Publicado: (2023)

Screening strategies for non-alcoholic fatty liver disease: a holistic approach is needed
por: Kasper, Philipp, et al.
Publicado: (2023)

Non-invasive diagnosis and staging of non-alcoholic fatty liver disease
por: Kechagias, Stergios, et al.
Publicado: (2022)

Advances in the Diagnosis and Treatment of Non-Alcoholic Fatty Liver Disease
por: Yin, Xunzhe, et al.
Publicado: (2023)

Docosahexaenoic acid and non-alcoholic fatty liver disease in obese children: a novel approach?
por: Verduci, Elvira, et al.
Publicado: (2015)

Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
por: Dowman, J K, et al.
Publicado: (2011)

The effect of moderate alcohol consumption on nonalcoholic fatty liver disease
por: Park, Ji-Won, et al.
Publicado: (2023)

Non-Alcoholic Fatty Liver Disease and Cardiovascular Comorbidities: Pathophysiological Links, Diagnosis, and Therapeutic Management
por: Jichitu, Alexandra, et al.
Publicado: (2021)

Management of Dyslipidemia in Patients with Non-Alcoholic Fatty Liver Disease
por: Martin, Anna, et al.
Publicado: (2022)

Recommendations for the management of non-alcoholic fatty liver disease (NAFLD)
por: Tomasiewicz, Krzysztof, et al.
Publicado: (2018)

Non-alcoholic fatty liver diseases: update on the challenge of diagnosis and treatment
por: Oh, Hyunwoo, et al.
Publicado: (2016)

In search of the optimal management strategy for non‐alcoholic fatty liver disease in type 2 diabetes patients
por: Lee, Chi‐Ho, et al.
Publicado: (2020)

Autophagy in non-alcoholic fatty liver disease and alcoholic liver disease()
por: Khambu, Bilon, et al.
Publicado: (2018)

Non-alcoholic fatty liver disease in pregnancy, paving the way for adverse pregnancy outcome risk assessment
por: Kwon, Ja-Young
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_10qoeqjvr39c3rgakts4p8doju